Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Plos One|November 22, 2013
Robust expression of the human neonatal Fc receptor in a truncated soluble form and as a full-length membrane-bound protein in fusion with eGFPJohan Seijsing, Malin Lindborg, John Löfblom, et al.Nuclear Medicine and Biology|July 2, 2011
Influence of an aliphatic linker between DOTA and synthetic Z(HER2:342) Affibody molecule on targeting properties of the (111)In-labeled conjugateVladimir Tolmachev, Joachim Feldwisch, Malin Lindborg, et al.Biochemical and Biophysical Research Communications|October 22, 2008
Dimeric HER2-specific affibody molecules inhibit proliferation of the SKBR-3 breast cancer cell lineLina Ekerljung, Malin Lindborg, Lars Gedda, et al.Protein Engineering, Design & Selection : PEDS|August 9, 2013
High-affinity binding to staphylococcal protein A by an engineered dimeric Affibody moleculeMalin Lindborg, Anatoly Dubnovitsky, Kenneth Olesen, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 27, 2013
Site-specific radiometal labeling and improved biodistribution using ABY-027, a novel HER2-targeting affibody molecule-albumin-binding domain fusion proteinAnna Orlova, Andreas Jonsson, Daniel Rosik, et al.Cancer Research|March 3, 2007
Synthetic affibody molecules: a novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumorsAnna Orlova, Vladimir Tolmachev, Rikard Pehrson, et al.Proceedings of the National Academy of Sciences of the United States of America|November 20, 2014
An engineered affibody molecule with pH-dependent binding to FcRn mediates extended circulatory half-life of a fusion proteinJohan Seijsing, Malin Lindborg, Ingmarie Höidén-Guthenberg, et al.Pageof 1